LV11940A - Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas - Google Patents

Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas

Info

Publication number: LV11940A
Authority: LV; Latvia
Prior art keywords: melatonin; grass; dependent; people; treatment
Prior art date: 1995-02-01

Application number

LV970144A

Other languages

English (en)

Other versions

LV11940B (lv

Inventor

Nava Zisapel

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-01

Filing date

1997-07-24

Publication date

1998-01-20

1995-02-01 Priority claimed from US08/381,535 external-priority patent/US6469044B1/en

1997-07-24 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

1998-01-20 Publication of LV11940A publication Critical patent/LV11940A/lv

1998-05-20 Publication of LV11940B publication Critical patent/LV11940B/lv

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

LVP-97-144A 1995-02-01 1997-07-24 Melatonīna pielietojums personu ārstēšanai, kuras cieš no zāļu atkarības LV11940B (lv)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/381,535 US6469044B1 (en)	1995-02-01	1995-02-01	Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en)	1995-02-01	1995-06-06	Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en)	1995-02-01	1996-01-29	Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number	Publication Date
LV11940A true LV11940A (lv)	1998-01-20
LV11940B LV11940B (lv)	1998-05-20

Family

ID=26140195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-97-144A LV11940B (lv)	1995-02-01	1997-07-24	Melatonīna pielietojums personu ārstēšanai, kuras cieš no zāļu atkarības

Country Status (22)

Country	Link
JP (1)	JP4516159B2 (lv)
CN (1)	CN1083263C (lv)
AT (1)	AT408188B (lv)
AU (1)	AU695366B2 (lv)
BG (1)	BG62876B1 (lv)
BR (1)	BR9607169A (lv)
CZ (1)	CZ291349B6 (lv)
DK (1)	DK176081B1 (lv)
EE (1)	EE03384B1 (lv)
FI (1)	FI119586B (lv)
IS (1)	IS1980B (lv)
LU (1)	LU90118B1 (lv)
LV (1)	LV11940B (lv)
MD (1)	MD1716C2 (lv)
NO (1)	NO312814B1 (lv)
NZ (1)	NZ298878A (lv)
PL (1)	PL183148B1 (lv)
SI (1)	SI9620022A (lv)
SK (1)	SK284521B6 (lv)
TR (1)	TR199700723T1 (lv)
TW (1)	TW483757B (lv)
WO (1)	WO1996023496A1 (lv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL150190A0 (en)	2000-01-05	2002-12-01	Neurim Pharma 1991	Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) *	2002-04-28	2012-10-31	Neurim Pharma 1991	Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en)	2003-04-29	2013-12-31	Neurim Pharma 1991	Insomnia treatment
US9119846B2 (en)	2003-04-29	2015-09-01	Neurim Pharmaceuticals (1991) Ltd.	Method and composition for enhancing cognition in alzheimer's patients
EP4502609A3 (en)	2012-01-26	2025-04-09	Vanda Pharmaceuticals Inc.	Determining a circadian rhythm
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
ES2805376T3 (es)	2012-12-18	2021-02-11	Vanda Pharmaceuticals Inc	Tasimelteón para el tratamiento de trastornos del ritmo circadiano
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
CN109922795B (zh) *	2016-10-31	2021-10-08	纽里姆药物有限公司	褪黑素小片剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69229490T2 (de) *	1991-05-09	2000-02-17	Neurim Pharmaceuticals (1991) Ltd., Tel Aviv	Melatonin enthaltende Arzneimittel
IT1251544B (it) *	1991-05-13	1995-05-17	Gabriele Biella	Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

1996
- 1996-01-29 CN CN96191750A patent/CN1083263C/zh not_active Expired - Lifetime
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/xx unknown
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/cs not_active IP Right Cessation
- 1996-01-29 NZ NZ298878A patent/NZ298878A/xx not_active IP Right Cessation
- 1996-01-29 PL PL96321630A patent/PL183148B1/pl unknown
- 1996-01-29 SI SI9620022A patent/SI9620022A/sl not_active IP Right Cessation
- 1996-01-29 SK SK1030-97A patent/SK284521B6/sk unknown
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 AT AT0901396A patent/AT408188B/de not_active IP Right Cessation
- 1996-01-29 BR BR9607169A patent/BR9607169A/pt not_active Application Discontinuation
- 1996-01-29 JP JP52338596A patent/JP4516159B2/ja not_active Expired - Lifetime
- 1996-01-29 EE EE9700166A patent/EE03384B1/xx not_active IP Right Cessation
- 1996-01-29 MD MD97-0254A patent/MD1716C2/ro not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/zh not_active IP Right Cessation
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/lv unknown
- 1997-07-25 IS IS4532A patent/IS1980B/is unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/da not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/bg unknown
- 1997-07-31 NO NO19973531A patent/NO312814B1/no not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/fi not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/fr active

Also Published As

Publication number	Publication date
FI973185A0 (fi)	1997-07-31
NO312814B1 (no)	2002-07-08
MD1716B2 (en)	2001-08-31
SK284521B6 (sk)	2005-05-05
BG101803A (en)	1998-04-30
FI973185L (fi)	1997-09-30
SK103097A3 (en)	1998-01-14
IS4532A (is)	1997-07-25
AU695366B2 (en)	1998-08-13
FI119586B (fi)	2009-01-15
CZ240597A3 (cs)	1998-01-14
BG62876B1 (bg)	2000-10-31
AU4457496A (en)	1996-08-21
LV11940B (lv)	1998-05-20
NO973531D0 (no)	1997-07-31
WO1996023496A1 (en)	1996-08-08
AT408188B (de)	2001-09-25
BR9607169A (pt)	1997-11-11
NO973531L (no)	1997-09-30
PL321630A1 (en)	1997-12-08
DK176081B1 (da)	2006-04-18
PL183148B1 (pl)	2002-05-31
MD970254A (en)	1999-05-31
JPH10513177A (ja)	1998-12-15
CN1083263C (zh)	2002-04-24
DK89697A (da)	1997-07-30
TR199700723T1 (xx)	1998-02-21
CZ291349B6 (cs)	2003-02-12
NZ298878A (en)	1999-05-28
MD1716C2 (ro)	2002-02-28
TW483757B (en)	2002-04-21
SI9620022A (sl)	1998-10-31
EE9700166A (et)	1998-02-16
EE03384B1 (et)	2001-04-16
ATA901396A (de)	2001-02-15
JP4516159B2 (ja)	2010-08-04
LU90118B1 (fr)	1997-11-13
IS1980B (is)	2005-01-14
CN1172431A (zh)	1998-02-04
MX9705856A (es)	1998-07-31

Publication	Publication Date	Title
NO991381D0 (no)	1999-03-22	Kombinasjonsterapi for behandling av psykoser
NO982172D0 (no)	1998-05-13	Anvendelse av epinastin for behandling av smerter
NO976063D0 (no)	1997-12-23	Fremgangsmåte for behandling av diabetes
FI952721A7 (fi)	1995-12-04	Aine maksa-sappi-sairauksien hoitamiseksi
DE69600307D1 (de)	1998-06-25	Beatmungsgerät zur Behandlung von Ateminsuffizienzen
FI971568A0 (fi)	1997-04-14	Menetelmä resistenttien kasvainten hoitamiseksi
DK19893A (da)	1993-08-25	Praeparat til nasal behandling
DE69620691D1 (de)	2002-05-23	Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO991459L (no)	1999-03-25	Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
LV11940A (lv)	1998-01-20	Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas
NO983512D0 (no)	1998-07-30	Midler for behandling og forhindring av AIDS
PT932400E (pt)	2003-03-31	Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
FI971527A7 (fi)	1997-04-11	Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO984432L (no)	1998-11-24	FremgangsmÕte for behandling av migrenesmerte
DE69604071D1 (de)	1999-10-07	Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
NO994258L (no)	1999-11-02	Anvendelse av levobupivakain for behandling av ansiktsmigrene
NO913117L (no)	1992-02-11	Fremgangsmaate for behandling av benoedeleggende sykdommer.
EE9700235A (et)	1998-04-15	Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO982562D0 (no)	1998-06-04	Sammensetning for behandling av smerte
DE69739190D1 (de)	2009-02-12	Arzneimittel zur behandlung von oculären kreislauferkrankungen
DE69840432D1 (de)	2009-02-26	Arzneimittel zur behandlung der augen
NO974529D0 (no)	1997-09-30	Innretning for tilförselen av alfuzosin gjennom huden
NO984189D0 (no)	1998-09-11	Fremgangsmåte for behandling av bipolar forstyrrelse
NO20002481D0 (no)	2000-05-12	Kombinasjonsterapi for behandling av AIDS
DE69615396D1 (de)	2001-10-25	Derivate von 5-naphthalin-1-yl-1,3-dioxanen, ihre herstellung und therapeutische anwendung